YucaiWangMD

PubMed

• Defining Primary Refractory Large B-cell Lymphoma.
  Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, U...> ;Blood Advances. 2024 Apr 26
• 2 citations
  Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality.
  Kai Rejeski, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Munoz, Razan Mohty, Veit ...> ;Blood Advances. 2024 Apr 23
• A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
  Paul Joseph Hampel, Kerry A Rogers, Wei Ding, Saad S Kenderian, Sameer A Parikh, Mahesh Swaminathan, Erin M Parry, Jan A Burger, Matthew S Davids, Alessandra Ferrajoli...> ;Blood Advances. 2024 Mar 27
• Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
  Truong, H., Barreto, J., Mara, K., Hampel, P., Micallef, I., Nowakowski, G., Thanarajasingam, G., Thompson, C., Wang, Y., Witzig, T., Herrmann, S., Leung, N.> ;JCO Oncology Practice. 2024 Feb 26
• Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy.
  Radhika Bansal, Paschalis Vergidis, Pritish K Tosh, John Wilson, Matthew Hathcock, Arushi Khurana, N Nora Bennani, Jonas Paludo, Jose C Villasboas, Yucai Wang, Stephen...> ;Transplantation and Cellular Therapy. 2024 Apr 1
• Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.
  Tun, A., Bisneto, J., Wang, Y., Maliske, S., Micallef, I., Inwards, D., Habermann, T., Porrata, L., Paludo, J., Rosenthal, A., Kharfan-Dabaja, M., Ansell, S., Nowakows...> ;Haematologica. 2024 Jan 18
• The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R C...> ;American Journal of Hematology. 2024 Mar 1
• Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
  Dong-Won Kang, Li Wang, Nicholas J Short, Alessandra Ferrajoli, Yucai Wang, Shouhao Zhou, Chan Shen> ;Pharmacoeconomics. 2024 Apr 1
• Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for larg...
  Karan L Chohan, Radhika Bansal, Matthew A Hathcock, Jonas Paludo, Nora N Bennani, Patrick B Johnston, Arushi Khurana, Urshila Durani, Yucai Wang, Michael W Ruff, Jose ...> ;Leukemia & Lymphoma. 2024 Mar 1
• Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzu...
  Matthew J Maurer, Carla Casulo, Melissa C Larson, Thomas M Habermann, Izidore S Lossos, Yucai Wang, Loretta J Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin...> ;Haematologica. 2023 Nov 30
• 1 citations
  Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
  Allison M Bock, Jennifer J Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew J Maurer, Brian F Kabat, Jonas Paludo, David J Inwards...> ;Blood Cancer Journal. 2023 Nov 13
• Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
  Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Jessica F Burlile, Saad S Kenderian, Yucai Wang, Eli Muchtar, Amber B Koehler, Susan M Schwag...> ;American Journal of Hematology. 2023 Nov 1
• 2 citations
  Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
  William G Breen, Jason R Young, Matthew A Hathcock, Roman O Kowalchuk, Matthew P Thorpe, Radhika Bansal, Arushi Khurana, N Nora Bennani, Jonas Paludo, Jose Villasboas ...> ;Blood Cancer Journal. 2023 Aug 18
• 3 citations
  The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene aut...
  Kai Rejeski, Yucai Wang, Omar Albanyan, Javier Munoz, Pierre Sesques, Gloria Iacoboni, Lucia Lopez-Corral, Isabelle Ries, Veit L Bücklein, Razan Mohty, Martin Dreyling...> ;American Journal of Hematology. 2023 Nov 1
• 22 citations
  The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
  Kai Rejeski, Doris K Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M Logue, Eva Bräunlein, David M Cordas Dos Santos, Ciara L Freeman, Melissa A...> ;Journal of Hematology & Oncology. 2023 Jul 31
• 1 citations
  Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma.
  Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, Patrick B J...> ;Haematologica. 2023 Nov 1
• 2 citations
  Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
  Wiedmeier-Nutor, J., Iqbal, M., Rosenthal, A., Bezerra, E., Garcia-Robledo, J., Bansal, R., Johnston, P., Hathcock, M., Larsen, J., Bergsagel, P., Wang, Y., Reeder, C....> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
• 5 citations
  Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
  Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A Eyre, Chan Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian Flinn, Benoit Tessouli...> ;Journal of Clinical Oncology. 2023 Aug 20
• 5 citations
  Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy.
  Bezerra, E., Iqbal, M., Munoz, J., Khurana, A., Wang, Y., Maurer, M., Bansal, R., Hathcock, M., Bennani, N., Murthy, H., Rosenthal, A., Paludo, J., Villasboas, J., Joh...> ;Blood Advances. 2023 Apr 25
• Review of management options for mantle cell lymphoma in pregnancy.
  Yucai Wang, Allison M Bock, Dragan Jevremovic, Michael L Wang, Grzegorz S Nowakowski, Wern Lynn Ng> ;Leukemia & Lymphoma. 2023 Jun 1
• 1 citations
  Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant.
  Yucai Wang, Aasiya Matin, David J Inwards, Thomas M Habermann, Ivana Micallef, Patrick B Johnston, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenth...> ;Hemasphere. 2023 Apr 1
• 36 citations
  Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
  Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew J Maurer, Matthew J Frank, Javier L Munoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P Mcguirk,...> ;Journal of Clinical Oncology. 2023 May 10
• 6 citations
  Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.
  Marissa Z Powell, Kristin C Mara, Radhika Bansal, Matthew A Hathcock, Arushi Khurana, N Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M Anse...> ;Cancer Medicine. 2023 Apr 1
• 2 citations
  Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
  Aldo A Acosta-Medina, Isla McKerrow Johnson, Radhika Bansal, Matthew Hathcock, Saad J Kenderian, Urshila Durani, Arushi Khurana, Yucai Wang, Jonas Paludo, Jose C Villa...> ;Blood Cancer Journal. 2023 Jan 5
• 5 citations
  Central nervous system involvement by mantle cell lymphoma.
  Nicole McLaughlin, Yucai Wang, Thomas Witzig, Jose Villasboas, Thomas Habermann, David Inwards, Nora Bennani, Gita Thanarajasingam, Grzegorz Nowakowski, Luis Porrata, ...> ;Leukemia & Lymphoma. 2023 Feb 1
• Join now to see all

Abstracts/Posters

• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
  Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Outcomes of stem cell transplant in patients with Richter transformation. 
  2019 ASCO Annual Meeting - 6/1/2019
• Efficacy of frontline treatment regimens in follicular lymphoma: A network meta-analysis of phase III randomized controlled trials. 
  2019 ASCO Annual Meeting - 6/1/2019
• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Distinct immune signatures in chronic lymphocytic leukemia (CLL) and Richteras syndrome (RS). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• Join now to see all